

Progressive familial intrahepatic cholestasis: сlinicalе features and genetic heterogeneity
https://doi.org/10.25557/2073-7998.2025.08.82-84
Abstract
Introduction. Progressive familial intrahepatic cholestasis (PFIC) is a genetically heterogeneous liver disease leading to cirrhosis and liver failure. Early diagnosis and a personalized treatment approach are essential.
Methods. A total of 25 probands with PFIC were examined. A clinical and genetic analysis was performed, including targeted gene panel sequencing and whole-exome sequencing.
Results. The most common form of the disease was PFIC type 2. The median age of disease onset was 1.5 months. The most frequent symptoms included cholestasis, hepatomegaly, pruritus, and hemorrhagic syndrome. A total of 19 pathogenic and 6 likely pathogenic variants were identified, including novel mutations in the ABCB11, USP53, MYO5B, ABCB4, and ATP8B1 genes.
Conclusions. Genetic variant verification enables personalized therapy selection, including bile acid transporter inhibitors, and facilitates decision-making regarding liver transplantation timing.
About the Authors
E. Yu. NuzhnayaRussian Federation
115522; 1, Moskvorechie st.; Moscow
E. A. Gusarova
Russian Federation
115522; 1, Moskvorechie st.; Moscow
A. V. Efremovа
Russian Federation
115522; 1, Moskvorechie st.; Moscow
T. V. Strokova
Russian Federation
109240; 2/14, Ustinsky proezd; Moscow
N. N. Taran
Russian Federation
115522; 1, Moskvorechie st.; 109240; 2/14, Ustinsky proezd; Moscow
A. R. Morgul
Russian Federation
115522; 1, Moskvorechie st.; Moscow
M. V. Sharova
Russian Federation
115522; 1, Moskvorechie st.; Moscow
P. A. Vasiliev
Russian Federation
115522; 1, Moskvorechie st.; Moscow
D. V. Gorodilova
Russian Federation
115522; 1, Moskvorechie st.; Moscow
F. M. Bostanova
Russian Federation
115522; 1, Moskvorechie st.; Moscow
A. S. Kuchina
Russian Federation
115522; 1, Moskvorechie st.; Moscow
A. E. Voskanyan
Russian Federation
115522; 1, Moskvorechie st.; Moscow
E. Yu. Zakharova
Russian Federation
115522; 1, Moskvorechie st.; Moscow
N. A. Semenova
Russian Federation
115522; 1, Moskvorechie st.; Moscow
References
1. Srivastava A. Progressive Familial Intrahepatic Cholestasis. J Clin Exp Hepatol. 2014 г.;4(1):25–36.
2. Amirneni S., Haep N., Gad M.A., et al. Molecular overview of progressive familial intrahepatic cholestasis. World J Gastroenterol. 2020;26(47):7470-7484.
3. Vinayagamoorthy V., Srivastava A., Sarma M.S. Newer variants of progressive familial intrahepatic cholestasis. World J Hepatol. 2021;13(12):2024–38.
4. Maddirevula S., Shagrani M., Ji A.R,. et al. Large-scale genomic investigation of pediatric cholestasis reveals a novel hepatorenal ciliopathy caused by PSKH1 mutations. Genet Med. 2024;26(11):101231.
5. Ryzhkova O.P., Kardymon O.L., Prohorchuk E.B., et al. Rukovodstvo po interpretatsii dannykh posledovatel’nosti DNK cheloveka, poluchennykh metodami massovogo parallel’nogo sekvenirovaniya (MPS) (redaktsiya 2018, versiya 2) [Guidelines for the interpretation of massive parallel sequencing variants (update 2018, v2)]. Meditsinskaya genetika [Medical Genetics]. 2019;18(2):3-23. (In Russ.)
6. Baker A., Kerkar N., Todorova L., et al. Systematic review of progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol. 2019;43(1):20–36.
7. Torfenejad P., Geramizadeh B., Haghighat M., et al. Progressive Familial Intrahepatic Cholestasis and its Subtypes: The First Report From Iran. Inn J Pediatr.2016;26(6):e6497.
Review
For citations:
Nuzhnaya E.Yu., Gusarova E.A., Efremovа A.V., Strokova T.V., Taran N.N., Morgul A.R., Sharova M.V., Vasiliev P.A., Gorodilova D.V., Bostanova F.M., Kuchina A.S., Voskanyan A.E., Zakharova E.Yu., Semenova N.A. Progressive familial intrahepatic cholestasis: сlinicalе features and genetic heterogeneity. Medical Genetics. 2025;24(8):82-84. (In Russ.) https://doi.org/10.25557/2073-7998.2025.08.82-84